Method for primary prevention of allergic disorders during infancy through ige-class-specific immunosuppression

摘要

A method for preventing the onset of allergic disorders in infancy and later is provided. A pharmaceutical composition comprising an anti-IgE antibody that suppresses the production of allergen-specific IgE antibodies in infancy, which is accomplished by administration of said pharmaceutical composition to a pregnant mother and/or a child at any point from after birth to infancy. A pharmaceutical composition comprising an anti-IgE antibody for suppressing IgE-class-specific immune responses during the fetal stage to infancy, which is accomplished by administration of said pharmaceutical composition to a pregnant mother and/or a child at any point from after birth to infancy.